Department of medical physiology 3 rd week
|
|
- Mariah Lynch
- 6 years ago
- Views:
Transcription
1 Department of medical physiology 3 rd week Semester: winter Study program: Dental medicine Lecture: RNDr. Soňa Grešová, PhD. Department of medical physiology Faculty of Medicine PJŠU
2 Department of medical physiology 3 rd week 1. Platelets morfology, production, account, function 2. Blood clotting, haemocoagulation factors 3. Group antigens, blood transfusion
3 1. Prevention of Blood Clotting in the Normal Vascular System Intravascular Anticoagulants Endothelial Surface Factors a) the smoothness of the endothelial cell surface -NO, PGI 2 inactivate receptors of Tr againts aggregation, - ADP adenosin diphosphatase against adherence of Tr b) glycocalyx - repels clotting factors and platelets, thereby preventing activation of clotting c) thrombomodulin which binds thrombin and activates a plasma protein, protein C - anticoagulant by inactivating activated Factors V and VIII.
4 1. Prevention of Blood Clotting in the Normal Vascular System Intravascular Anticoagulants Antithrombin Action of Fibrin and Antithrombin III. alpha-globulin called antithrombin III or antithrombin-heparin cofactor Heparin combines with antithrombin III, the effectiveness of antithrombin III for removing thrombin increases - anticoagulant by inactivating activated Thrombin and Factors XII, XI, X and IX Activation of Plasminogen to Form Plasmin injured tissues and vascular endothelium release a powerful activator called tissue plasminogen activator (t-pa)
5 1. Platelets morfology, production, account, function Platelets or thrombocytes are small colorless, non nucleated cells Shape is spherical or rod shaped and become oval or disc shaped when inactivated volume 6-9 fl (10-15 l) average 2-4 µl < microthrombocyts > macrothrombocyts thickness 1µm Platelets x10 9 /l ( /mm 3 ) Lifespan 10 days TROMBOCYTOSIS intense muscle work, altitude -hypoxia, dehydration, myeloproliferative disorders. TROMBOCYTOPENIA insufficient production, overbleeding < l, functionless < l,
6 Cell Lines in Blood Cell Formation (Hematopoiesis) Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier.
7 1. Platelets structure Cell Membrane of Platelet It is 6 nm thick and contain lipids - phospholipids, cholesterol, glycolipids - Carbohydrates(glycocalyx) Glycopropteins -form a receptor for ADP and thrombin - receptors (glykoproteins): GP Ib adherence; GP IIb a GP IIIa - aggregation Phospholipids - accelerate clotting reactions. - form precursors for thromboxane A 2
8 1. Platelets structure Cytoplasm Tubular systems Dense tubular system - it is the main calcium storage Opened tubular system - it is creatived by numeorus invaginations and it is for releasing of content from granules Fibrous structurs Submembrane filaments and mikrotubuls - they maintain the discoid shape and position of organels in nonactive platelets Cytoplasmatic mikrofilaments - they are responsible for contraction at the releasing granular content
9 1. Platelets structure Cytoplasm Proteins The major proteins present are contractile proteins which are responsible for the contraction of platelets: Actin Myosin Thrombosthenin Fibrin-stabilizing factor (PF XIII) : clotting factor Platelet derived growth factor (PDGF) : helps repair damaged vascular walls. Enzymes The enzymes present are adenosine triphosphatase and the enzymes necessary for the synthesis of prostaglandin. Hormones Adrenaline vascular and Serotonin local tissue reactions Histamine Chemical substances: Calcium ions Mg- ions. Adenosine triphosphate (ATP) Adenosine diphosphate (ADP)
10 1. Platelets structure Cytoplasm Granules α granula - PF 1 proaccelerin (f.v) - PF2 β - thromboglobulin, which supports the transformation of fibrinogen to fibrin - PF 3 thromboplastic factor - PF 4 antiheparine factor - PF 5 platelet fibrinogen - factor of permeability, which increases permeability of the vessel wall δ granula (dense granules) - ADP and ATP - Ca2+ - Serotonine λ- granula - they are lysosomes and contain the acidic hydrolases, glucuronidese, β- galactosidase, elastase, colagenese and others
11 1. Platelets function PARTIPICIPATION ON HEMOSTATIC PROCESSES - application of the mechanical and humoral action PARTICIPATION ON INFLAMMATORY PROCESSES - realesing of platelet activating factor (PAF), which is mediator of inflammatory and alergic reactions - activation of phospholipase A2 and production of the important inflammatory substances (prostaglandins, leucotriens, thromboxan)
12 2. Blood clotting, haemocoagulation factors 1. Vessel reactions in the place of damage 2. Platelet activity a) adhesion b) change of the shape and releasing reaction c) aggregation 3. Haemocoagulation Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier.
13 2. Blood clotting, haemocoagulation factors 1. Vessel reactions in the place of damage VASOCONSTRICTION REFLEX - it is allowed by the smooth muscle cell contraction as the direct response of the vessel wall for damage - sympathetic mediates it and duration of this event is some minutes or hours HUMORAL - substances producing vasoconstriction are from platelets mainly serotonine, but also substances as adrenaline, thromboxan A2, fibrinopeptids and fibronektine.
14 2. Blood clotting, haemocoagulation 2. Platelet activity - it consists in contact with collagen fibres through specific receptors on the platelet membrane (GP Ib) and with the certain binding places of the collagen molecule a) adhesion: factors Negative influence: production of the instable prostacykline (PGI2), which is produced by endothelial cells of the vessel wall Positive influence: von Willebrand s factor, thrombin, ADP
15 2. Blood clotting, haemocoagulation factors b) change of the shape and releasing reaction - platelets acquire the spheric shape - by the mechanism of the active contraction (presence of actin and myosin in the cytoplasma) pseudopodia subendothelium fibres-bound are produced SECRETION - ADP stimulates the platelet aggregation - vonwillebrand s factor supports the platelet adhesion - fibronektin supports the platelet adhesion - serotonin supports the vasoconstriction - growth factor (PDGF Platelet-derived Growth Factor) mitogenic effect - thromboxan A2 supports the vasoconstriction and platelet aggregation - PAF (Platelet Activating Factor) activates not only next platelets but also phagocytes
16 2. Blood clotting, haemocoagulation c) aggregation factors - Primary phase of aggregation aggregation is in progress after adhesion of the first platelet layer on the vessel wall. This phase is still reversible. - binding of platelets by fibrinogen through fibrin receptors (GP IIb/IIIa) COMPLEX of AGGREGATION: secondary phase of aggregation (irreversible). -binding between platelets and fibrinogen is stronger under influence of thrombospondine (protein from α-granules)
17 3. 2. Blood clotting, haemocoagulation factors Haemocoagulation - Haemocoagulation factors Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier.
18 2. Blood clotting, haemocoagulation 3. Haemocoagulation factors a) Intrinsic pathway b) Extrinsic pathway
19 3. Haemocoagulation a) Intrinsic pathway Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier.
20 3. Haemocoagulation - Extrinsic pathway Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier.
21 3. Haemocoagulation Polymerization of fibrinogen Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier.
22 3. Fibrinolysis
23 Bleeding Time Duke s Method Make a small incision or finger prick, and dab the end of the finger on a paper every 30 sec. until the bleeding stops. Count the number of the blots and divide by 2 Normal bleeding time is 1 6 min. Abnormal bleeding time: Blood vessel defect, platelet defect, thrombocytopenia
24 Clotting Time To collect blood in a chemically clean glass test tube and then to tip the tube back and forth about every 30 seconds until the blood has clotted. By this method, the normal clotting time is 6 to 10 minutes
25 3. Group antigens, blood transfusion Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier.
26 3. Group antigens, blood transfusion Heredity of blood groups Copyright: Hall, J. E., & Guyton, A. C. (2006). Guyton and Hall textbook of medical physiology. Philadelphia, PA: Saunders Elsevier. Copyright: Kujanik,S., & col. (1998). Practical lesson in physiology. Košice: Medical faculty UPJS.
27 Rh Blood Types Rh antigens are designated C,D, E, c, d, and e Rh positive (D antigen) Rh negative (person who does not have type D antigen)
28 Blood Type Pathology Hemolytic Disease of the Newborn (Erythroblastosis Fetalis) the mother is Rh negative and the father Rh positive The baby has inherited the Rh-positive antigen from the father, and the mother develops anti-rh agglutinins from exposure to the fetus s Rh antigen
29 3. Principles of the blood transfusion plasma from donor cannot clott blood cells of recipient give blood the same group, subgroup and Rh factor 1. Cross-matching 2. Biological examination 3. In the case negative reaction, the biological examination repeat still 2x 4. After the stopping of transfusion to monitor pacient 2-4 hours is needed
Sign up to receive ATOTW weekly -
BLOOD PHYSIOLOGY PART 2 ANAESTHESIA TUTORIAL OF THE WEEK 231 11 TH JULY 2011 Dr Karen Hayes Royal Devon & Exeter Correspondence to: kmhayes@hotmail.co.uk QUESTIONS Before continuing, try to answer the
More informationCoagulation Mechanisms Dr. Nervana Bayoumy
Coagulation Mechanisms Dr. Nervana Bayoumy Associate Professor Department of Physiology Objectives At the end of this lecture you should be able to: 1. Recognize the different clotting factors 2. Understand
More informationHemostasis and Thrombosis
Hemostasis Hemostasis and Thrombosis Normal hemostasis is a consequence of tightly regulated processes that maintain blood in a fluid state in normal vessels, yet also permit the rapid formation of a hemostatic
More informationAdv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file:
Adv Pathophysiology Unit 4 Page 1 of 10 Learning Objectives for this file: Topics include structure & function of: 1. Coagulation process platelets, clotting factors 2. Coagulation cascade formation of
More informationIntroduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO
Introduction Hemostasis: Tourniquet Test & Bleeding Time Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO Hemostasis A series of reactions that function to stop bleeding, maintaining
More informationLocal vasoconstriction. is due to local spasm of the smooth muscle (symp. reflex) can be maintained by platelet vasoconstrictors
Hemostasis Hemostasis ( hemo =blood; sta= remain ) is the stoppage of bleeding, which is vitally important when blood vessels are damaged. Following an injury to blood vessels several actions may help
More informationCh 13: Blood. What does blood do? Transport: Regulation: Protection:
Ch 13: Blood What does blood do? Transport: Regulation: Protection: SLOs Describe the composition of plasma and list the major functions of plasma proteins. Map hematopoiesis, starting from a pluripotent
More informationHemostasis. by Mohie-Aldien Elsayed
Hemostasis by Mohie-Aldien Elsayed Hemostasis Hemostasis is defined as the process that maintains the flowing blood in a fluid state and confined to the circulatory system Coagulation prevents excess blood
More informationGeneral Principles of. Hemostasis. Kristine Krafts, M.D.
General Principles of Hemostasis Kristine Krafts, M.D. Hemostasis is a balancing act! pro-ting plugs up holes in blood vessels anti-ting keeps ting under control Pro-Clotting Pro-Clotting vessels platelets
More informationThese handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.
These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides. If you would like the 1 slide per page handouts, please ask
More informationOverview of Anatomy and Physioloy II Second Year Students
University of Baghdad College of Nursing Department of Basic Medical Sciences Overview of Anatomy and Physioloy II Second Year Students Asaad Ismail Ahmad, Ph.D. Asaad Ismail Ahmad, Ph.D. Electrolyte and
More informationChapter 19b Blood, cont d
Chapter 19b Blood, cont d White Blood Cells WBCs account for less than 1% of blood volume. There are two major histological categories of WBCs the granulocytes and the agranulocytes. GRANULOCYTES are Basophils,
More informationPhysiology Unit 3 HEMATOLOGY
Physiology Unit 3 HEMATOLOGY In Physiology Today Hematocrit Percentage of blood volume that is erythrocytes 45% in men 42% in women Average blood volume in is 5 L Plasma Large amounts of organic/inorganic
More informationThe Cardiovascular System: Blood
The Cardiovascular System: Blood The Functions of Blood General Overview Provides a system for rapid transport within the body Nutrients Hormones Waste products Respiratory gases Cells & Blood Components
More informationHaemostasis. The function of haemostasis is: to prevent blood loss from injured vessels. to stop bleeding. to prevent thrombosis
Haemostasis Haemostasis The function of haemostasis is: to prevent blood loss from injured vessels to stop bleeding to prevent thrombosis Haemostasis blood endothelium basement membrane subendothelium
More informationDr. Suzana Voiculescu
Dr. Suzana Voiculescu Overview of hemostasis Initiated when trauma, surgery or disease disrupts the vascular endothelium, exposing blood to the subendothelial connective tissue Achieved by: 1)Vasconstriction
More informationMethods of Biomaterials Testing. Special Biology: Blood & Vessel
Methods of Biomaterials Testing Special Biology: Blood & Vessel Blood Compatibility Mainly: Inhibition of blood clot formation Materials in Bloodflow Venous catheter Dialysis filter Dialysis shunt Heart
More informationSession 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy
~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 1 of 4 Session 1 Topics Review of coagulation and the vascular phase of hemostasis Unfractionated heparin Low molecular
More informationHaematologY. Dr Tom Bate Again!
HaematologY Dr Tom Bate Again! THE FRCA What you need to know Blood Groups ~30 blood group systems recognised (ISBT) ABO, Rhesus, Lewis, Kell, Duffy, Kidd MNS system, Kell system The ABO antigens are the
More informationBlood is 55% Plasma (Liquid)
Blood is 55% Plasma (Liquid) The plasma portion of blood is: 91% Water Maintains blood volume Transports molecules 7% Proteins (ie: clotting proteins, albumin, immunoglobulins ) 2 % Salts, gases (O 2,
More informationThe Coagulation Workup In The Office Setting
CAA Conference alm Springs 2012 The Coagulation Workup In The Office Setting CAA Conference alm Springs, October 2012 Robert Miller, A-C Henoch-Schoenlein urpura 1 CAA Conference alm Springs 2012 2 CAA
More informationCoagulation in perspective: Blood management. Objectives
Coagulation in perspective: Blood management Julie Wegner, PhD jawrbl@gmail.com Objectives To gain a basic understanding of the following: 1. Coagulation components and processes Why patients bleed. 2.
More informationBiochemistry of connective tissue Pathochemistry of inflammation
Biochemistry of connective tissue Pathochemistry of inflammation Outline: 1. Biochemistry of connective tissue 2. Healing of wounds 3. Pathochemistry of wound healing 4. Sources 1. Connective tissue Tissue
More informationBLOOD COAGULATION. 1. The initial phase of the process is vascular constriction. This limits the flow of blood to the area of injury.
BLOOD COAGULATION The ability of the body to control the flow of blood following vascular injury is paramount to continued survival. The process of blood clotting and then the subsequent dissolution of
More informationPharmacology Lecture 5. Anticoagulants
Pharmacology Lecture 5 Anticoagulants General overview Anti-thrombotic Drugs Antiplatlets Anticoagulants Fibrinolytics Anticoagulants Indirect Thrombin Inhibitors Anti-thrombotic effect is exerted by interaction
More information2013 Health Press Ltd.
Fast Facts Fast Facts: Bleeding Disorders Second edition David Green MD PhD Professor of Medicine Emeritus Feinberg School of Medicine Northwestern University Chicago, Illinois, USA Christopher A Ludlam
More informationLABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY
LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY 1 WHEN IS THE LAB REQUIRED TO INVESTIGATE FOR A POSSIBLE BLEEDING DISORDER? Clinically suspected bleeding tendency
More informationP. W. HOWIE M.D., M.R.C.O.G. first method of activation is the intrinsic system. Hageman factor, which in turn activates a series of
Postgraduate Medical Journal (May 1979) 55, 362-366 Blood clotting and fibrinolysis in pregnancy P. W. HOWIE M.D., M.R.C.O.G. MRC Unit of Reproductive Biology, Edinburgh Summary During normal pregnancy,
More informationVeins Valves prevent engorgement and backflow. Baroreceptor reflex. Veins returning blood
Veins have large radii and low resistance. Walls are thin, not elastic Most blood volume is in veins Veins returning blood Veins Valves prevent engorgement and backflow Sympathetic NS constricts veins
More informationCommon Inherited Bleeding Disorders
CAA 2015 Annual Conference Common Inherited Bleeding Disorders Bob Miller, A October 8, 2015 VWF has two jobs Loosely bound to protect FVIII and tether to site of injury All other coagulation factors also
More informationDisclaimer: this is a very big topic and coverage will be only superficial.
Vascular Biology 4 Blood and its components: 1 Disclaimer: this is a very big topic and coverage will be only superficial. 1. Erythrocytes: eat your spinach (or steak). ~8 um diameter, 2 um thickness no
More informationLABORATORY DIAGNOSIS OF BLEEDING DISORDERS
LABORATORY DIAGNOSIS OF BLEEDING DISORDERS Primary & Secondary Hemostasis Disorders http://.columbia.edu/itc/hs/medical/selective/advclinicalpathology/2004/lecture/lab%20diagnosis%20of%20bleeding%20disorders.ppt
More informationCHROMOGENIC SUBSTRATE TECHNOLOGY. Giovanni Russi
CHROMOGENIC SUBSTRATE TECHNOLOGY Giovanni Russi What is a chromogenic substrate? A peptide linked to a chromophore The peptide is formed by 3-5 residues The chromophore is p-nitroaniline (p-na) The residues
More informationVeins Valves prevent engorgement and backflow. Baroreceptor reflex. Veins returning blood
Veins have large radii and low resistance. Walls are thin, not elastic Most blood volume is in veins Veins returning blood Veins Valves prevent engorgement and backflow Sympathetic NS constricts veins
More informationCoagulation. Coagulation Limited CGL, CGDF Surveys & Anatomic Pathology Education Programs. Coagulation 117
www.cap.org Coagulation Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Serviced (CMS). Coagulation Limited CGL, CGDF Analyte CGL CGDF New
More informationPrimary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system
Primary hemostasis Vascular endothelium Vasoconstriction : local tissue factor, nervous system Platelet Plug Platelet Adhesion Platelet Activation Platelet Aggregation Platelet Plug Formation Secondary
More informationCardiovascular (connective tissue)
Cardiovascular (connective tissue) Blood Connective tissue Blood Proteins 7% Plasma 55% Other solutes 2% Water 91% Erythrocytes ~5.2 million per cubic mm Formed elements 45% Leukocytes ~7 thousand per
More informationSerine Proteases and their Inhibitors
ugo Kubinyi, www.kubinyi.de Serine Proteases and their Inhibitors ugo Kubinyi Germany E-Mail kubinyi@t-online.de omepage www.kubinyi.de ugo Kubinyi, www.kubinyi.de Serine Proteases of Physiological Importance
More informationOVERVIEW OF LABORATORY DIAGNOSTIC TESTING FOR PLATELET DISORDERS
OVERVIEW OF LABORATORY DIAGNOSTIC TESTING FOR PLATELET DISORDERS Catherine P. M. Hayward, MD PhD, FRCP(C) Head, Coagulation, Hamilton Regional Laboratory Medicine Program Professor, Pathology and Molecular
More informationBasic coagulation applications and case studies
Basic coagulation applications and case studies Jing Jin Clinical laboratory Scientist (MLS, ASCP) - Coagulation/Hematology Stanford University Hospital and Clinics 1 Agenda Overview about 3 major phases
More informationEnzyme Research Laboratories product list 2018
Milan Analytica AG Baslerstrasse 15 4310 Rheinfelden Switzerland www.milananalytica.ch Enzyme Research Laboratories product list 2018 Product # Sizes/quantity Human Proteins Human Prothrombin Prothrombin
More informationHaemostasis Reagents product list 2018
Milan Analytica AG Baslerstrasse 15 4310 Rheinfelden www.milananalytica.ch Product # ** = Smaller Kit Format specifically designed for Helena C-1/2/4/AC-4 ^ = For use with Helena C-1/2/4/AC-4 Product name
More informationproteins. The ECs are supported by a collagen-rich
CE Update [coagulation and hematology] An Overview of Hemostasis Henry O. Ogedegbe, PhD, BB(ASCP)SC Department of Environmental Health, Molecular and Clinical Sciences, Florida Gulf Coast University, Fort
More informationb. No intercellular fibers 1. Intracellular fluid (ICF) -- 2/3 of total 2. Extracellular fluids (ECF) 1/3 of total
INTRODUCTION 2013 William A. Olexik Concept A. Tissue 1. Connective 2. Exceptional a. Only liquid tissue b. No intercellular fibers 3. Part of cardiovascular system B. Body Fluid 1. Intracellular fluid
More informationSpecial Coagulation - APC Resistance. DiaPharma Group, Inc. Customer Service: Technical Support:
Special Coagulation - APC Resistance DiaPharma Group, Inc. Customer Service: 1.800.526.5224 Technical Support:1.800.447.3846 www.diapharma.com 1 Review of Hemostasis Overview Pathways of coagulation, anticoagulation,
More informationI. Functions: A. Transport material exchange B. Regulatory homeostasis. Temp, ph, C. Prevention defense, clotting
Chapter 11 Blood I. Functions: A. Transport material exchange B. Regulatory homeostasis Temp, ph, C. Prevention defense, clotting II. Characteristics: A. Red body fluid (atrial redder than venous) B. 100.4
More informationHematology Emergencies: Problems with Platelets
Hematology Emergencies: Problems with Platelets Christian Cable, MD, FACP Associate Professor of Medicine Division of Hematology & Oncology Texas A&M HSC College of Medicine Scott & White Healthcare Fundamentals
More informationCommon Inherited Coagulation Disorders. Inherited Coagulation Disorders. All coagulation factors and platelets in circulation (unactivated)
Common Inherited Coagulation Disorders Bob Miller, A 2017 Inherited Coagulation Disorders Brief review of coagulation Disorders related to platelet dysfunction (not the acquired thrombocytopenias) Disorders
More informationIndex. Autoimmune thrombocytopenic purpura (AITP), 100, 102, 105, 108, 187 Automated platelet counters, , 108
A Accuracy, 6, 7, 15, 46, 52, 53, 61, 75, 100, 143, 144, 149, 166, 176, 178 Acquired coagulation disorders, 111 115 Acquired platelet disorders, 99 108 ACT. See Activated clotting time (ACT) Activated
More information*NCCT is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program, provider #122.
COURSE DESCRIPTION Have you ever wondered why the blood that a phlebotomist collects in a tube will form a clot unless certain chemicals are added to the tube in advance to prevent it? Have you ever wondered
More informationCOAGULATION: BASIC PRINCIPLES. Peyman Eshghi Prof. of Pediatric Hematology & Oncology
COAGULATION: BASIC PRINCIPLES Peyman Eshghi Prof. of Pediatric Hematology & Oncology 1395 Haemostasis overview: BV Injury Neural Contact/ Tissue Factor Blood Vessel Constriction Reduced Blood flow Platelet
More informationBE.430/2.795//6.561/10.539/HST.544. Final Exam. Handed out: Monday, Dec. 6, 2004 Due: Thursday, Dec. 9 by 5pm
BE.430/2.795//6.561/10.539/HST.544 Final Exam Handed out: Monday, Dec. 6, 2004 Due: Thursday, Dec. 9 by 5pm Problem 1 (30 %) ALG Notes Problem 2.6.3 Parts a f (not g) (Page 199) Problem 2 (35 %) When patients
More informationCoagulopathy Case-2. Andy Nguyen, M.D. 2009
Coagulopathy Case-2 Andy Nguyen, M.D. 2009 CLINICAL HISTORY A 42 year-old man brought to the emergency room with severe burn. Patient was rescued by firemen in a serious fire. He had been found unconscious
More informationROTEM Basic Interpretation Guide
ROTEM Basic Interpretation Guide Parameter: Clotting Time CT - Clotting Time (seconds) The time from the start of the test until first significant levels of a clot are detected. This measurement is initiated
More informationCase 1. Case 1. Case 2. Case 2. Review of Bleeding Disorders Case 1
Review of Bleeding Disorders Case 1 Robert I. Handin, MD Professor of Medicine, Harvard Medical School Hematology Division Brigham & Women s Hospital 20 year college student is home on spring break and
More informationPlasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems.
Test Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems. Karen A. Moffat BEd, MSc, ART, FCSMLS(D) Technical Specialist, Coagulation, HRLMP Assistant Professor, Department of
More informationUsing TEG in the ED, OR, and ICU. Don H. Van Boerum, MD, FACS
Using TEG in the ED, OR, and ICU Don H. Van Boerum, MD, FACS Trauma Surgeon, Director of Surgical Critical Care, Co-Director of Shock Trauma ICU, Intermountain Medical Center, Intermountain Healthcare
More informationThe effects of hypothermia and acidosis on Haemostasis
The effects of hypothermia and acidosis on Haemostasis By Luis Figueiredo de Sousa A thesis submitted to the De Montfort University for the degree of Master of Philosophy Faculty of Life Sciences De Montfort
More informationDr. Susan Louw Haematopathologist NHLS / WITS / SASTH
Dr. Susan Louw Haematopathologist NHLS / WITS / SASTH Since 1948 Initially a research tool Utility in management of bleeding and thrombosis Guide clotting factor replacement, platelet / blood transfusions
More informationPerson responsible (Chair): Martine Jandrot-Perrus, Hans Deckmyn
NAME OF PROJECT: Measurement of platelet activation markers: usefulness, current practices, future. Subcommittee: Platelet physiology Person responsible (Chair): Martine Jandrot-Perrus, Hans Deckmyn Design:
More informationPlatelet type bleeding: (vwd) - Petechiae, purpura, ecchymoses, bruising - Menorrhagia, hematuria, occult GI bleed - Gingival bleeding, epistaxis
1 Nadanotes.com 2 Nadanotes.com 3 Nadanotes.com Platelet type bleeding: (vwd) - Petechiae, purpura, ecchymoses, bruising - Menorrhagia, hematuria, occult GI bleed - Gingival bleeding, epistaxis Clotting
More informationFarnesoid X Receptor and its ligands inhibit the function of platelets
Farnesoid X Receptor and its ligands inhibit the function of platelets Article Accepted Version Figures and Legends Moraes, L. A., Unsworth, A. J., Vaiyapuri, S., Ali, M. S., Sasikumar, P., Sage, T., Flora,
More informationCoagulation Cascade. TF-VIIa. Tissue Factor + VII. XIIa. Prothrombin. XIa. IXa. VIIIa. Thrombin. XL- Fibrin. XIII Monomer. Fibrinogen.
Coagulation Cascade Intrinsic Pathway Extrinsic Pathway Contact Activation XIIa XI XIa Prekallikrein HMW Kininogen IX IXa Ca 2+ Anticoagulation proteins: Protein C, Protein S, Antithrombin III, TFPI TF
More informationSystem of protein filaments in the cytoplasm of. eukaryotic cell that gives the cell shape and capacity for
Cytoskeleton System of protein filaments in the cytoplasm of eukaryotic cell that gives the cell shape and capacity for directed movement. The protein filaments are responsible for the shaping, moving,
More informationBNG 331 Cell-Tissue Material Interactions. Wound Healing I
BNG 331 Cell-Tissue Material Interactions Wound Healing I Course update LBL 4 Friday; paper posted Need a volunteer to switch groups! Much better job on LBL 3 figure summaries BNG spring seminar 3 this
More informationCell-Extracellular Matrix Interactions
Cell-Extracellular Matrix Interactions Extracellular Matrix (ECM) Organised network outside of the cell s plasma membrane Between cells Composition varies throughout the ECM Continuous sheet of ECM = Basement
More informationRheological and biochemical analyses on blood coagulation ~ Discovery of a new pathway under stagnant flow conditions ~
Rheological and biochemical analyses on blood coagulation ~ Discovery of a new pathway under stagnant flow conditions ~ Computer and Information Division, RIKEN Hiroki Iwata Supramolecular Science Laboratory,
More informationImmunomodulation at Cardiac Surgery. William T McBride MD
Immunomodulation at Cardiac Surgery William T McBride MD March 2005 Basic Structure of Immune System Immune response Adaptive specific memory Innate non-specific no memory ADAPTIVE (specific) b INNATE
More informationPrincess Alexandra Hospital Emergency Department. Clinical Procedure. 1 Introduction
Princess Alexandra Hospital Emergency Department Clinical Procedure Trauma, Resuscitation Review Officer: Glenn Ryan 1 Introduction Version no: 1 Approval Date: 16/07/2014 Review Date: 16/07/2016 Authority:
More informationROZAIMAH ZAIN-HAMID. Department of Pharmacology and Therapeutics Faculty of Medicine, Universitas Sumatera Utara
ROZAIMAH ZAIN-HAMID Department of Pharmacology and Therapeutics Faculty of Medicine, Universitas Sumatera Utara Drugs Used in Disorders of Coagulation Fibrinolytic drugs Anti-thrombotic thrombotic drugs
More informationLina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof
2 Lina Al-Lawama Rama Al-Ashqar Malik Al-Zohlof Anticoagulant drugs Recap Last lecture we were talking about antiplatelet drugs, we mentioned 5 drugs : Aspirin which is used alone with patents that have
More informationFactor Concentrates. More is better? Alexander Duncan MD Emory Medical Labs
Factor Concentrates. More is better? Alexander Duncan MD Emory Medical Labs Call from OR! Scenario -1 Patients is bleeding out! Don t ask why, what rate what s been done! We need blood now! What kind of
More informationClinical Procedure. ROTEM Trauma, Resuscitation. Princess Alexandra Hospital Emergency Department. 1 Introduction
Princess Alexandra Hospital Emergency Department Clinical Procedure Trauma, Resuscitation Review Officer: Glenn Ryan 1 Introduction Version no: 1 Approval Date: 16/07/2014 Review Date: 16/07/2016 Authority:
More informationPROVINCIAL BLOOD COORDINATING PROGRAM DEFINITIONS NLBCP-063
Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program PROVINCIAL BLOOD COORDINATING PROGRAM DEFINITIONS Office of Administrative Responsibility
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Evaluation of Medicines for Human Use London, 29 July 2004 CPMP/BPWG/1089/00 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE CLINICAL INVESTIGATION OF PLASMA
More informationLABORATORY APPROCH TO THE BLEEDING PATIENT
Anne Winkler, MD Emory University School of Medicine, Atlanta Georgia Assistant Professor, Pathology & Laboratory Medicine Medical Director, Transfusion Service, Grady Health System Assistant Director,
More informationHEMOCOMPATIBILITY AND ENDOTHELIALIZATION OF ELASTIN AND COLLAGEN SCAFFOLDS: THE ROLE OF PLASMA PROTEINS, SHEAR STRESS AND INTEGRINS
Clemson University TigerPrints All Theses Theses 8-2010 HEMOCOMPATIBILITY AND ENDOTHELIALIZATION OF ELASTIN AND COLLAGEN SCAFFOLDS: THE ROLE OF PLASMA PROTEINS, SHEAR STRESS AND INTEGRINS Nithya Swaminathan
More informationRheological Properties of Fibrin Clots
Rheological Properties of Fibrin Clots A THESIS SUBMITTED TO THE UNIVERSITY OF MANCHESTER FOR THE DEGREE OF MASTER OF PHILOSOPHY IN THE FACULTY OF ENGINEERING AND PHYSICAL SCIENCES Year of submission 2012
More informationLaboratory Testing Issues for Protein C, Protein S and Antithrombin Assays
Laboratory Testing Issues for Protein C, Protein S and Antithrombin Assays Richard A. Marlar Ph.D. University of Oklahoma THSNA Meeting- Chicago, IL April 14-16, 2016 DISCLOSURE Richard A. Marlar, PhD
More informationMarcia L. Zucker, Ph.D. ZIVD LLC
Marcia L. Zucker, Ph.D. ZIVD LLC 1 Monitoring hemostasis Bleeding Clotting 2 3 Extrinsic Pathway Monitor with ACT / aptt WARFARIN Monitor with PT Common Pathway X II Xa LMWH & DXaI IIa (thrombin) Hirudin
More informationSupplementary Figure 1 Pfn1, but not other Pfn isoforms are expressed in
Supplementary Figure 1 Pfn1, but not other Pfn isoforms are expressed in platelets. (a) RT-PCR of Pfn isoforms in control mouse platelets, Pfn1 -/- platelets and control heart. Expected band size for Pfn1
More informationHaemostasis Antibodies
HAEMOSTASIS ANTIBODIES FROM CEDARLANE www.cedarlanelabs.com NEW! The study of haemostasis and thrombosis has become one of the most rapidly growing fields in medical research. An unprecedented amount of
More informationLaboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016
Laboratory investigation in the Bleeding Patient Dr Craig Taylor Consultant Haematologist May 2016 Introduction Bleeding is common May consume significant resources Crossmatched blood Lab results may be
More informationMarcia L. Zucker, Ph.D. ZIVD LLC
Marcia L. Zucker, Ph.D. ZIVD LLC 1 Explain why ACTs from different systems are not the same Develop a plan for switching from one ACT system to another Describe why ACT and aptt are not interchangeable
More informationThe Power in You. TM
RegenKit THT Autologous Platelet Rich Plasma (A-PRP) The Power in You. TM Biologics Concentrated on Healing RegenKit THT Autologous Platelet Rich Plasma (A-PRP) The RegenKit THT is designed to be used
More informationDrugs used in Thromboembolic Disease. Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014
Drugs used in Thromboembolic Disease Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2014 Drugs used in Thromboembolic Disease Anticoagulants: Heparin. Oral anticoagulants.
More informationThe COAGULATION CASCADE:
The COAGULATION CASCADE: From Chaos to Control Blood Day 2018 Health Science Centre Winnipeg, MB Becky Rock, RN Program Coordinator: Patient Blood Management Program Alberta Health Services: Calgary Zone
More informationManejo de la transfusión de plaquetas. Ileana López-Plaza, MD
Manejo de la transfusión de plaquetas Ileana López-Plaza, MD Thrombocytopenia Common in ICU setting 25-38% with< 100,000/µL 2-3 % with < 10,000/µL Common etiologies Drug-induced: heparin, antibiotics,
More informationHaemostasis Antibodies
HAEMOSTASIS ANTIBODIES FROM CEDARLANE www.cedarlanelabs.com NEW! The study of haemostasis and thrombosis has become one of the most rapidly growing fields in medical research. An unprecedented amount of
More informationInherited bleeding disorders: disorders of platelet adhesion and aggregation
Critical Reviews in Oncology/Hematology 49 (2004) 1 35 Inherited bleeding disorders: disorders of platelet adhesion and aggregation Indra Ramasamy Department of Chemical Pathology, Newham General Hospital,
More informationVIII. Validation Evaluation Comparative Chart Application Fields of PRP Advantages of MiroPRP for skin treatments MicroPRP and Mico-Mesotherapy
The New Technology for Safe Platelet Activation INDEX I. Blood Composition II. What is PRP Therapy? III. Growth Factors Present in PRP IV. Why is PRP concentration significant? V. How are Platelets Activated?
More informationBivalirudin (Angiomax ) vs. Heparin during Peripheral Vascular Interventions: Which is Better and How to Decide?
Bivalirudin (Angiomax ) vs. Heparin during Peripheral Vascular Interventions: Which is Better and How to Decide? Vinod Nair MD FACC FSCAI Cardiovascular Ins6tute of the South, Houma Financial Disclosure:
More informationMutagenesis and Expression of Mammalian Clotting Factor IX. Mark McCleland The Children s Hospital of Philadelphia and Lycoming College
Mutagenesis and Expression of Mammalian Clotting Factor IX Mark McCleland The Children s Hospital of Philadelphia and Lycoming College Hemophilia B X-linked blood clotting disorder characterized by a deficiency
More informationDisclosures. I have received research funding from: I have received consulting fees/honoraria from: Novo Nordisk CSL-Behring Boehringer Ingelheim
Test Disclosures I have received research funding from: Novo Nordisk CSL-Behring Boehringer Ingelheim I have received consulting fees/honoraria from: Novo Nordisk CSL-Behring Baxter The Medicines Company
More informationHematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม
Hematotoxin producing snakes in Thailand พญ.ม ชฌ มา รอดเช อ พญ.อ สร ย หาญอ ท ยร ศม Hematotoxin producing snakes Pit vipers (Crotalinae) Malayan pit viper (Calloselasma rhodostoma) Green pit viper (Trimeresurus
More information10/8/2013. Drug-induced immune thrombocytopenia (DITP) Clinical aspects
Richard Aster, MD Blood Center of Wisconsin, Blood Research Institute, Milwaukee, WI Senior Investigator Medical College of Wisconsin Professor, Departments of Medicine & Pathology Drug-induced immune
More informationPlatelet Factor IV- Heparin Antibodies. Presenter: Michael J. Warhol, M.D.
Platelet Factor IV- Heparin Antibodies Presenter: Michael J. Warhol, M.D. Learning Objectives Describe the mechanism of interaction between Heparin and Platelet Factor 4 Review the chemistry of Heparin
More informationCONTRACTING ORGANIZATION: University of Texas Southwestern Medical Center Dallas, TX
AD Award Number: W81XWH-12-1-0152 TITLE: Effects of Thermal Status on Markers of Blood Coagulation During Simulated Hemorrhage PRINCIPAL INVESTIGATOR: Craig G. Crandall, Ph.D. CONTRACTING ORGANIZATION:
More informationDe l'utilisation de la microscopie intravitale pour étudier la thrombose in vivo et tester de nouveaux médicaments antithrombotiques- 1er partie
De l'utilisation de la microscopie intravitale pour étudier la thrombose in vivo et tester de nouveaux médicaments antithrombotiques- 1er partie Christophe Dubois INSERM UMR-S-1076, Faculté de Pharmacie,
More informationDr. Vivien Chen [FINAL REPORT: KANEMATSU Final report for Vivien Chen: Kanematsu Memorial Award Outcomes:
Final report for Vivien Chen: Kanematsu Memorial Award 2011 Outcomes: Thank you awarding me the 2011 Kanematsu Memorial Award. The grant has been instrumental in setting up this project and helping establish
More information